Dr. Scott Addison, MD

NPI: 1548236888
Total Payments
$3,599
2024 Payments
$15.14
Companies
31
Transactions
300
Medicare Patients
898
Medicare Billing
$65,177

Payment Breakdown by Category

Food & Beverage$3,529 (98.0%)
Education$70.80 (2.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,529 288 98.0%
Education $70.80 12 2.0%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $521.00 59 $0 (2020)
Novo Nordisk Inc $463.00 41 $0 (2024)
Amgen Inc. $361.29 20 $0 (2020)
GlaxoSmithKline, LLC. $308.83 36 $0 (2018)
AstraZeneca Pharmaceuticals LP $274.40 12 $0 (2019)
Boehringer Ingelheim Pharmaceuticals, Inc. $188.31 17 $0 (2019)
Amarin Pharma Inc. $174.22 17 $0 (2020)
Janssen Pharmaceuticals, Inc $163.76 13 $0 (2019)
Novartis Pharmaceuticals Corporation $130.21 9 $0 (2020)
Sunovion Pharmaceuticals Inc. $127.70 3 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $15.14 1 Novo Nordisk Inc ($15.14)
2023 $17.94 1 Novo Nordisk Inc ($17.94)
2022 $18.22 1 ABBVIE INC. ($18.22)
2020 $245.08 15 Amgen Inc. ($54.13)
2019 $1,223 97 Novo Nordisk Inc ($221.44)
2018 $1,132 87 PFIZER INC. ($181.50)
2017 $948.55 98 GlaxoSmithKline, LLC. ($157.88)

All Payment Transactions

300 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
06/26/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $15.14 General
Category: Diabetes
11/17/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $17.94 General
Category: Diabetes
11/03/2022 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $18.22 General
Category: NEUROSCIENCE
03/11/2020 Amgen Inc. Aimovig (Biological), Otezla, Repatha Food and Beverage In-kind items and services $18.77 General
Category: Neuroscience
03/09/2020 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $15.41 General
Category: Cardiovascular
02/27/2020 Neos Therapeutics, LP Adzenys XR-ODT (Drug), Cotempla XR-ODT Food and Beverage In-kind items and services $11.59 General
Category: ADHD
02/20/2020 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $17.54 General
Category: Neuroscience
02/19/2020 Novo Nordisk Inc Ozempic (Drug), RYBELSUS Food and Beverage In-kind items and services $11.95 General
Category: Diabetes
02/13/2020 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $12.81 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
02/11/2020 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $17.97 General
Category: Cardiovascular
02/03/2020 Supernus Pharmaceuticals, Inc. TROKENDI XR (Drug) Food and Beverage Cash or cash equivalent $23.08 General
Category: AED
01/23/2020 Novo Nordisk Inc Food and Beverage In-kind items and services $17.82 General
01/17/2020 Mylan Specialty L.P. Yupelri (Drug) Food and Beverage In-kind items and services $12.99 General
Category: Respiratory and Allergy
01/16/2020 Teva Pharmaceuticals USA, Inc. AJOVY (Biological) Food and Beverage In-kind items and services $14.58 General
Category: Central Nervous System
01/13/2020 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $17.82 General
Category: Neuroscience
01/10/2020 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $15.86 General
Category: CARDIOVASCULAR
01/06/2020 PFIZER INC. CHANTIX (Drug), ELIQUIS Food and Beverage In-kind items and services $13.73 General
Category: NEUROSCIENCE;TOBACCO DEPENDENCE
01/03/2020 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $23.16 General
Category: Cardiovascular
12/21/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug), INVOKANA Food and Beverage In-kind items and services $11.79 General
Category: Cardiovascular & Metabolism
12/13/2019 Amarin Pharma Inc. Vascepa (Drug) Food and Beverage In-kind items and services $24.77 General
Category: Hypertriglyceridemia
12/13/2019 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $21.20 General
Category: Diabetes
12/13/2019 Amarin Pharma Inc. Vascepa (Drug) Education In-kind items and services $5.90 General
Category: Hypertriglyceridemia
12/11/2019 PFIZER INC. COLOGUARD (Device) Food and Beverage In-kind items and services $14.53 General
Category: GASTROINTESTINAL
12/11/2019 PFIZER INC. COLOGUARD (Device) Food and Beverage In-kind items and services $1.98 General
Category: GASTROINTESTINAL
11/22/2019 Novo Nordisk Inc Food and Beverage In-kind items and services $14.81 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 187 254 $43,206 $13,400
2022 3 253 390 $63,826 $19,800
2021 2 244 365 $56,315 $19,806
2020 2 214 296 $41,576 $12,171
Total Patients
898
Total Services
1,305
Medicare Billing
$65,177
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 123 180 $33,660 $10,356 30.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 64 74 $9,546 $3,044 31.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 158 256 $47,872 $15,067 31.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 84 122 $15,738 $4,676 29.7%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Office 2022 11 12 $216.00 $57.44 26.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 166 249 $42,738 $14,548 34.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 78 116 $13,577 $5,257 38.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 129 179 $28,998 $8,364 28.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 85 117 $12,578 $3,807 30.3%

About Dr. Scott Addison, MD

Dr. Scott Addison, MD is a Family Medicine healthcare provider based in Norton Shores, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548236888.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Addison, MD has received a total of $3,599 in payments from pharmaceutical and medical device companies, with $15.14 received in 2024. These payments were reported across 300 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,529).

As a Medicare-enrolled provider, Addison has provided services to 898 Medicare beneficiaries, totaling 1,305 services with total Medicare billing of $65,177. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Norton Shores, MI
  • Active Since 02/27/2006
  • Last Updated 01/11/2022
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1548236888

Products in Payments

  • CHANTIX (Drug) $291.69
  • Tresiba (Drug) $175.36
  • Vascepa (Drug) $174.22
  • Aimovig (Biological) $134.60
  • ELIQUIS (Drug) $132.95
  • SYMBICORT (Drug) $128.16
  • ENTRESTO (Drug) $115.03
  • Prolia (Biological) $107.74
  • FARXIGA (Drug) $107.67
  • XARELTO (Drug) $99.44
  • SEEBRI (Drug) $96.67
  • Repatha (Biological) $81.77
  • JARDIANCE (Drug) $80.69
  • VIAGRA (Drug) $76.64
  • Ozempic (Drug) $76.23
  • ANORO (Drug) $71.59
  • PRADAXA (Drug) $71.23
  • ADVAIR (Drug) $70.09
  • INVOKANA (Drug) $64.32
  • LYRICA (Drug) $60.67

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Norton Shores